{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:50Z","timestamp":1790190770596,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.clim.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T15:01:41Z","timestamp":1489071701000},"page":"40-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["CD4 + FoxP3 + T regulatory cell subsets in myasthenia gravis patients"],"prefix":"10.1016","volume":"179","author":[{"given":"Siegfried","family":"Kohler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Oskar Philipp","family":"Keil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Swierzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Carsten","family":"R\u00fcckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2017.03.003_bb0005","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.03.003_bb0010","doi-asserted-by":"crossref","unstructured":"J.P. Sieb, Myasthenia gravis: an update for the clinician, Clin. Exp. Immunol., 175 408\u2013418.","DOI":"10.1111\/cei.12217"},{"key":"10.1016\/j.clim.2017.03.003_bb0015","doi-asserted-by":"crossref","unstructured":"M. Miyara, G. Gorochov, M. Ehrenstein, L. Musset, S. Sakaguchi, Z. Amoura, Human FoxP3+ regulatory T cells in systemic autoimmune diseases, Autoimmun. Rev., 10 744\u2013755.","DOI":"10.1016\/j.autrev.2011.05.004"},{"key":"10.1016\/j.clim.2017.03.003_bb0020","doi-asserted-by":"crossref","unstructured":"S. Gertel-Lapter, K. Mizrachi, S. Berrih-Aknin, S. Fuchs, M.C. Souroujon, Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model, Autoimmun. Rev., 12 894\u2013903.","DOI":"10.1016\/j.autrev.2013.03.009"},{"key":"10.1016\/j.clim.2017.03.003_bb0025","doi-asserted-by":"crossref","unstructured":"V. Nessi, S. Nava, C. Ruocco, C. Toscani, R. Mantegazza, C. Antozzi, F. Baggi, Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis, J. Immunol., 185 5656\u20135667.","DOI":"10.4049\/jimmunol.0903183"},{"key":"10.1016\/j.clim.2017.03.003_bb0030","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.180.4.2132","article-title":"Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis","volume":"180","author":"Aricha","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.03.003_bb0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2017.03.003_bb0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2249.2007.03442.x","article-title":"Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas","volume":"149","author":"Scarpino","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.03.003_bb0045","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.20340","article-title":"Selective loss of regulatory T cells in thymomas","volume":"56","author":"Strobel","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2017.03.003_bb0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s10875-007-9147-2","article-title":"Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy","volume":"28","author":"Fattorossi","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.03.003_bb0055","doi-asserted-by":"crossref","unstructured":"N. Matsui, S. Nakane, F. Saito, I. Ohigashi, Y. Nakagawa, H. Kurobe, H. Takizawa, T. Mitsui, K. Kondo, T. Kitagawa, Y. Takahama, R. Kaji, Undiminished regulatory T cells in the thymus of patients with myasthenia gravis, Neurology, 74 816\u2013820.","DOI":"10.1212\/WNL.0b013e3181d31e47"},{"key":"10.1016\/j.clim.2017.03.003_bb0060","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clim.2004.04.005","article-title":"Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy","volume":"112","author":"Sun","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2017.03.003_bb0065","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.0300-9475.2004.01410.x","article-title":"Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy","volume":"59","author":"Huang","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2017.03.003_bb0070","doi-asserted-by":"crossref","unstructured":"M. Thiruppathi, J. Rowin, B. Ganesh, J.R. Sheng, B.S. Prabhakar, M.N. Meriggioli, Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/\u2212) T cells in patients with myasthenia gravis, Clin. Immunol., 145 209\u2013223.","DOI":"10.1016\/j.clim.2012.09.012"},{"key":"10.1016\/j.clim.2017.03.003_bb0075","doi-asserted-by":"crossref","unstructured":"M. Thiruppathi, J. Rowin, Q. Li Jiang, J.R. Sheng, B.S. Prabhakar, M.N. Meriggioli, Functional defect in regulatory T cells in myasthenia gravis, Ann. N. Y. Acad. Sci., 1274 68\u201376.","DOI":"10.1111\/j.1749-6632.2012.06840.x"},{"key":"10.1016\/j.clim.2017.03.003_bb0080","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.0802046","article-title":"Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients","volume":"183","author":"Luther","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.03.003_bb0085","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2008-04-150524","article-title":"CD49d provides access to \"untouched\" human Foxp3+ Treg free of contaminating effector cells","volume":"113","author":"Kleinewietfeld","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clim.2017.03.003_bb0090","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2017.03.003_bb0095","doi-asserted-by":"crossref","unstructured":"K. Akesson, A. Tompa, A. Ryden, M. Faresjo, Low expression of CD39(+) \/CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+)\/CD129(+) on Treg cells in children with coeliac disease, Clin. Exp. Immunol., 180 70\u201382.","DOI":"10.1111\/cei.12559"},{"key":"10.1016\/j.clim.2017.03.003_bb0100","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.179.2.1322","article-title":"Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis","volume":"179","author":"Haas","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.03.003_bb0105","doi-asserted-by":"crossref","unstructured":"A.M. Thornton, P.E. Korty, D.Q. Tran, E.A. Wohlfert, P.E. Murray, Y. Belkaid, E.M. Shevach, Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells, J. Immunol., 184 3433\u20133441.","DOI":"10.4049\/jimmunol.0904028"},{"key":"10.1016\/j.clim.2017.03.003_bb0110","doi-asserted-by":"crossref","unstructured":"A. Marx, F. Pfister, B. Schalke, G. Saruhan-Direskeneli, A. Melms, P. Strobel, The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes, Autoimmun. Rev., 12 875\u2013884.","DOI":"10.1016\/j.autrev.2013.03.007"},{"key":"10.1016\/j.clim.2017.03.003_bb0115","doi-asserted-by":"crossref","unstructured":"I. Caramalho, H. Nunes-Cabaco, R.B. Foxall, A.E. Sousa, Regulatory T-Cell Development in the Human Thymus, Front. Immunol., 6 395.","DOI":"10.3389\/fimmu.2015.00395"},{"key":"10.1016\/j.clim.2017.03.003_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-200101000-00012","article-title":"Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors","volume":"25","author":"Okumura","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.clim.2017.03.003_bb0125","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","article-title":"The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients","volume":"94","author":"Okumura","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clim.2017.03.003_bb0130","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nature03886","article-title":"Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus","volume":"436","author":"Watanabe","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clim.2017.03.003_bb0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20020110","article-title":"Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes","volume":"196","author":"Annunziato","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2017.03.003_bb0140","article-title":"Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans","volume":"190","author":"Himmel","year":"2001","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2017.03.003_bb0145","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.4049\/jimmunol.1090105","article-title":"Comment on \"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells\"","volume":"185","author":"Verhagen","year":"2010","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2017.03.003_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008111.pub2","article-title":"Thymectomy for non-thymomatous myasthenia gravis","author":"Cea","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.clim.2017.03.003_bb0155","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.03.003_bb0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2005.02220.x","article-title":"Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment","volume":"116","author":"Fattorossi","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2017.03.003_bb0165","doi-asserted-by":"crossref","unstructured":"K.G. Schmetterer, A. Neunkirchner, W.F. Pickl, Naturally occurring regulatory T cells: markers, mechanisms, and manipulation, FASEB J., 26 2253\u20132276.","DOI":"10.1096\/fj.11-193672"},{"key":"10.1016\/j.clim.2017.03.003_bb0170","doi-asserted-by":"crossref","unstructured":"A.W. Schadenberg, T. van den Broek, M.A. Siemelink, S.O. Algra, P.R. de Jong, N.J. Jansen, B.J. Prakken, F. van Wijk, Differential homeostatic dynamics of human regulatory T-cell subsets following neonatal thymectomy, J. Allergy Clin. Immunol., 133 277\u2013280 e271-276.","DOI":"10.1016\/j.jaci.2013.08.030"},{"key":"10.1016\/j.clim.2017.03.003_bb0175","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(63)90456-2","article-title":"Systemic lupus erythematosus following thymectomy for mysthenia gravis. Report of two cases","volume":"2","author":"Alarcon Segovia","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2017.03.003_bb0180","first-page":"179","article-title":"Systemic lupus erythematosus following thymectomy for myasthenia gravis","volume":"16","author":"Petersen","year":"1969","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.clim.2017.03.003_bb0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM196401302700504","article-title":"Systemic lupus erythematosus, cirrhosis and ulcerative colitis after thymectomy for myasthenia gravis","volume":"270","author":"Galbraith","year":"1964","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.03.003_bb0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/archinte.1981.00340020115028","article-title":"Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Studies of suppressor cell function","volume":"141","author":"Calabrese","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.clim.2017.03.003_bb0195","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.1780340719","article-title":"A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy","volume":"34","author":"Grinlinton","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.03.003_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/096120339500400108","article-title":"Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature","volume":"4","author":"Mevorach","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2017.03.003_bb0205","doi-asserted-by":"crossref","unstructured":"H.A. Omar, M.A. Alzahrani, A.A. Al Bshabshe, A. Assiri, M. Shalaby, A. Dwedar, S.R. Abdulwahed, M.R. Hussein, Systemic lupus erythematosus after thymectomy for myasthenia gravis: a case report and review of the literature, Clin. Exp. Nephrol., 14 272\u2013276.","DOI":"10.1007\/s10157-009-0256-5"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616305873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616305873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T10:52:32Z","timestamp":1568890352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616305873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":41,"alternative-id":["S1521661616305873"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.03.003","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD4+ FoxP3+ T regulatory cell subsets in myasthenia gravis patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}